ARCHIVES

NCI Plans Brain Tumor Study To Determine Risk Factors, Exposures

This article is from The Cancer Letter archive.

Vol. 19 No. 16 | April 16, 1993

Download PDF Visit The Full Archive

Related Articles

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

September 26, 2014

Surprise Finding On HRT Stops Large Trial, Women Advised To Reconsider Long-Term Use Due to Increased Breast Cancer Risk

July 12, 2002

Accuracy Of Diagnostic Mammograms Varies By Radiologist, Study Finds

December 28, 2007

SWOG Wins Funding For H. Pylori Trial.

November 21, 2008

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

Fountain Displays Some Statesmanship

July 8, 1977